Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
peptidylprolyl isomerase E like pseudogene | 0.931 | 0.077 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2018 | |||||||||
|
SLC8A1 antisense RNA 1 | 0.792 | 0.231 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
TATA-box binding protein associated factor 9b pseudogene 2 | 0.861 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 271 | 0.769 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
FAS antisense RNA 1 | 0.695 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
schizophrenia 13 | 0.931 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
BACE1 antisense RNA | 0.760 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1592 | 0.821 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
IQCH antisense RNA 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2384 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
microRNA 2682 | 0.805 | 0.154 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1358 | 0.931 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1470 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
LAMA4 antisense RNA 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
MMADHC divergent transcript | 0.839 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 2109 | 0.821 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 2822 | 0.890 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
TPTEP2-CSNK1E readthrough | 0.678 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2003 | 2003 | |||||||||
|
Temple syndrome | 0.780 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
uncharacterized LOC105371807 | 0.686 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 |